Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan N Sabbagh

Showing results (11-20 of 269) with videos related to

Pageof 27
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|January 22, 2025
Perspective: Minimally clinically important "symptomatic" benefit associated with disease modification resulting from anti-amyloid immunotherapyJohn Alam, Marwan N Sabbagh
Expert Opinion on Investigational Drugs|August 25, 2022
COR388 (atuzaginstat): an investigational gingipain inhibitor for the treatment of Alzheimer diseaseMarwan N Sabbagh, Boris Decourt
Neurology and Therapy|December 14, 2019
Peripheral Biomarkers for Alzheimer's Disease: Update and ProgressMarwan N Sabbagh, Kaj Blennow
Journal of Alzheimer'S Disease : JAD|March 16, 2011
BACE1 as a potential biomarker for Alzheimer's diseaseBoris Decourt, Marwan N Sabbagh
Neurology and Therapy|May 23, 2015
Florbetaben for PET Imaging of Beta-Amyloid Plaques in the BrainDanielle Richards, Marwan N Sabbagh
Journal of Alzheimer'S Disease : JAD|February 26, 2010
Are certain lifestyle habits associated with lower Alzheimer's disease risk?Lana Arab, Marwan N Sabbagh
Journal of Nature and Science|May 12, 2015
Development and Validation of the Alzheimer's Questionnaire (AQ)Michael Malek-Ahmadi, Marwan N Sabbagh
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 10, 2016
An Appraisal of Novel Biomarkers for Evaluating and Monitoring Neurologic Diseases: Editorial IntroductionJeremy M Shefner, Marwan N Sabbagh
Alzheimer'S Research & Therapy|May 5, 2011
Investigational drugs for the treatment of AD: what can we learn from negative trials?Sandra A Jacobson, Marwan N Sabbagh
Expert Review of Neurotherapeutics|January 17, 2012
Statins to treat Alzheimer's disease: an incomplete storyMarwan N Sabbagh, D Larry Sparks
Pageof 27

Showing results (11-20 of 269) with videos related to

Sort By:
Pageof 27
Alzheimer'S & Dementia (New York, N. Y.)|January 22, 2025
Perspective: Minimally clinically important "symptomatic" benefit associated with disease modification resulting from anti-amyloid immunotherapyJohn Alam, Marwan N Sabbagh
Expert Opinion on Investigational Drugs|August 25, 2022
COR388 (atuzaginstat): an investigational gingipain inhibitor for the treatment of Alzheimer diseaseMarwan N Sabbagh, Boris Decourt
Neurology and Therapy|December 14, 2019
Peripheral Biomarkers for Alzheimer's Disease: Update and ProgressMarwan N Sabbagh, Kaj Blennow
Journal of Alzheimer'S Disease : JAD|March 16, 2011
BACE1 as a potential biomarker for Alzheimer's diseaseBoris Decourt, Marwan N Sabbagh
Neurology and Therapy|May 23, 2015
Florbetaben for PET Imaging of Beta-Amyloid Plaques in the BrainDanielle Richards, Marwan N Sabbagh
Journal of Alzheimer'S Disease : JAD|February 26, 2010
Are certain lifestyle habits associated with lower Alzheimer's disease risk?Lana Arab, Marwan N Sabbagh
Journal of Nature and Science|May 12, 2015
Development and Validation of the Alzheimer's Questionnaire (AQ)Michael Malek-Ahmadi, Marwan N Sabbagh
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 10, 2016
An Appraisal of Novel Biomarkers for Evaluating and Monitoring Neurologic Diseases: Editorial IntroductionJeremy M Shefner, Marwan N Sabbagh
Alzheimer'S Research & Therapy|May 5, 2011
Investigational drugs for the treatment of AD: what can we learn from negative trials?Sandra A Jacobson, Marwan N Sabbagh
Expert Review of Neurotherapeutics|January 17, 2012
Statins to treat Alzheimer's disease: an incomplete storyMarwan N Sabbagh, D Larry Sparks
Pageof 27